Patient Guide: A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 38 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05661578
Status: ACTIVE_NOT_RECRUITING
Condition: PD-L1-selected Solid Tumors
Phase: PHASE2

Find a Study Location Near You

This study is available at 38 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Spokane, Washington
  • Chongqing,
  • Tianjin,
  • • And 35 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily